Los Angeles/San Fernando Valley
Reed Neurological Research Building
10911 Weyburn Avenue, 2nd Floor
Los Angeles, CA 90095-7226
General Information: (310) 794-3665
Fax: (310) 794-3148
UCLA Appointments: (310) 794-1195
Centinela Freeman: (323) 563-5915
Olive View/UCLA Center: (818) 895-954
Website: UCLA ARCC Research Center
Principal Investigator: Jeffrey L. Cummings, M.D.
Medical Director: George Bartzokis, M.D.
The UCLA ARCC was established in 1985 and is an acclaimed facility for clinical research on Alzheimer's disease (AD) and related disorders. The Center has also been a federally-funded Alzheimer's Disease Core Center (ADCC) since 1991, and was awarded additional basic science research funding forming the current UCLA Center in April 1999. The State Alzheimer’s
Disease Research Center of California (ARCC) complements existing National Institute on Aging (NIA) funding and brings additional AD research and care resources to UCLA. The Center is directed by Jeffrey L. Cummings, M.D., who serves as the Principal Investigator and Medical Director of both the UCLA Center and the UCLA ARCC, and ensures the integration of cores and projects between both centers.
The UCLA ARCC is comprised of an interdisciplinary collaborative team of health-care professionals dedicated to improving the lives of patients with AD and their caregivers. The Center's goal is to discover the best means of optimizing the cognition, function, and behavior of the Alzheimer's patient and the quality of life of patients and their caregivers. The Center's team accepts the challenge of developing research, educational, and clinical programs appropriate to a multicultural society.
The UCLA ARCC offers patients and their caregivers access to diagnostic and treatment planning services, treatment with approved and experimental medications, and educational programs about AD and related dementias. The activities of the Center expand the opportunities for care and research activities at UCLA and affiliated sites, translating research advances for widespread community use, and developing information and programs with practical applications that improve the care of dementia patients and their caregivers.
Three active clinical research sites serve different ethnic populations: UCLA Medical Center, Drew Medical School/Martin Luther King Jr. Medical Center (Drew/King),and Olive View Medical Center. The patients cared for at UCLA Medical Center are largely
white, non-Hispanic; the population served by the Drew/King Memory Disorders and Cerebral Function Clinic is largely African American; and the population served by the Olive View Medical Center is nearly exclusively Hispanic. This structure of the Center allows clinicalactivities, research projects, and educational and translational activities to embrace three ethnic groups and provide data critically important for providing care to dementia victims in an ethnically and culturally diverse state such as California.